Extrapyramidal symptom profiles assessed with the Drug-Induced Extrapyramidal Symptom Scale: comparison with Western scales in the clinical double-blind studies of schizophrenic patients treated with either olanzapine or haloperidol.
about
Antipsychotic drug treatment for elderly people with late-onset schizophreniaAntipsychotic medication for early episode schizophreniaOlanzapine for schizophreniaBrexpiprazole: so far so goodEvaluation of akathisia in patients with schizophrenia, schizoaffective disorder, or bipolar I disorder: a post hoc analysis of pooled data from short- and long-term aripiprazole trials.The Barnes Akathisia Rating Scale--revisited.Itraconazole and domperidone: a placebo-controlled drug interaction study.Long-term efficacy and tolerability of quetiapine in patients with schizophrenia who switched from other antipsychotics because of inadequate therapeutic response-a prospective open-label study.Depressive morbidity and gender in community-dwelling Brazilian elderly: systematic review and meta-analysis.Treatment of depression in older adults.Pharmacokinetics and Safety of Brexpiprazole Following Multiple-Dose Administration to Japanese Patients With Schizophrenia.Scale for measuring self-recoverability in daily life for people with schizophrenia.Different safety profiles of risperidone and paliperidone extended-release: a double-blind, placebo-controlled trial with healthy volunteers.Switching antipsychotics to aripiprazole or blonanserin and plasma monoamine metabolites levels in patients with schizophrenia.
P2860
Q24203649-A50D7123-515D-4273-8BE3-EDFC7FC1A208Q24236683-C53C0BC3-5592-4F8D-9B27-AAF819E4C421Q24244031-DB2BFD6C-C141-459E-B65C-6DDCB2AED1B6Q26766401-DEC3B42F-D0AE-4B99-B459-60AB8804D26FQ33518314-98FECCCC-D35F-4175-8011-844D82FB91AFQ33975805-79A38241-7BEB-451F-9563-A80A56B941F1Q34261356-729DAB8F-FDCF-4141-9D2A-B6EEAE284C63Q35021026-259560CF-594C-43A7-8AFE-12204EACC203Q37755518-99053FD6-2DB0-473A-AFA4-9D4909BE0042Q38013058-9CC434BA-4488-4E2D-B685-92B48C0286A8Q47814439-68CA5A21-1D21-4903-AF2F-82A8907E7661Q49152319-5CD9A50C-54CB-4FB6-B8B8-0018B9E07B0BQ50757787-CCF60177-EF9C-41B5-8B4C-2821C77579D9Q51750647-1A5A1619-B987-47D1-8A4C-CE69F0EDEB2C
P2860
Extrapyramidal symptom profiles assessed with the Drug-Induced Extrapyramidal Symptom Scale: comparison with Western scales in the clinical double-blind studies of schizophrenic patients treated with either olanzapine or haloperidol.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh
2003年學術文章
@zh-hant
name
Extrapyramidal symptom profile ...... her olanzapine or haloperidol.
@en
Extrapyramidal symptom profile ...... her olanzapine or haloperidol.
@nl
type
label
Extrapyramidal symptom profile ...... her olanzapine or haloperidol.
@en
Extrapyramidal symptom profile ...... her olanzapine or haloperidol.
@nl
prefLabel
Extrapyramidal symptom profile ...... her olanzapine or haloperidol.
@en
Extrapyramidal symptom profile ...... her olanzapine or haloperidol.
@nl
P2093
P1476
Extrapyramidal symptom profile ...... her olanzapine or haloperidol.
@en
P2093
Charles M Beasley
Daniel J Walker
Toshiya Inada
Yoko Tanaka
P356
10.1097/00004850-200301000-00007
P577
2003-01-01T00:00:00Z